 |
|
 |
|
|
Gidazepam
|
|
| Systematic (IUPAC) name | |
| 2-(9-bromo- 3-oxo- 6-phenyl- 2,5-diazabicyclo [5.4.0] undeca- 5,8,10,12-tetraen- 2-yl) acetohydrazide | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H15BrN4O2 |
| Mol. mass | 387.2 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Schedule IV(US) |
| Routes | Oral |
Gidazepam is a drug which is an atypical benzodiazepine derivative, developed in the Soviet Union.[1][2] It is a selectively anxiolytic benzodiazepine.[3] It also has therapeutic value in the management of certain cardiovascular disorders.[4][5][6][7][8]
Gidazepam is a prodrug for its active metabolite 7-bromo-5-phenyl-1,2-di-hydro-3H-1,4- benzodiazepine-2-one (desalkylgidazepam).[9][10] It is used as an antianxiety. Its anxiolytic effects can take several hours to manifest after dosing however, as it is the active metabolite which primarily gives the anxiolytic effects.[11]
See also
References
- ^ Spasennikov, BA; Spasennikova (Sep 1991). "The new Soviet tranquilizer--gidazepam". Fel'dsher i akusherka 56 (9): 35–7. ISSN 0014-9772. PMID 1684941.
- ^ Neznamov, GG; Koshelev; Voronina; Trofimov (Mar 2002). "Experimental and clinical rationale for complex treatment of mental disorders in clean-up workers of the Chernobyl nuclear plant accident". Eksperimental'naia i klinicheskaia farmakologiia 65 (2): 12–6. ISSN 0869-2092. PMID 12109283.
- ^ Korkhov, VM; Tkachuk; Makan; Pavlovsky; Andronati (Feb 2002). "Affinities of gidazepam and its analogs for mitochondrial benzodiazepine receptors". Journal of receptor and signal transduction research 22 (1-4): 411–20. doi:. ISSN 1079-9893. PMID 12503630.
- ^ Morozov, IS; Barchukov; Neznamov (Jan 1998). "The effect of gidazepam on the cardiovascular system function in patients with neurotic reactions and in healthy subjects under aggravated conditions". Eksperimental'naia i klinicheskaia farmakologiia 61 (1): 30–2. ISSN 0869-2092. PMID 9575408.
- ^ Petrova, TR; Tatarkin (1994). "The neuroregulatory modulation of the hemodynamic reactions to physical loading in patients with cardiac arrhythmias". Terapevticheskii arkhiv 66 (9): 65–8. ISSN 0040-3660. PMID 7992218.
- ^ Skibitskiĭ, VV; Kanorskiĭ (Sep 1993). "New pharmacodynamic effects of gidazepam and befol in patients with cardiac arrhythmias". Eksperimental'naia i klinicheskaia farmakologiia 56 (5): 23–7. ISSN 0869-2092. PMID 7906171.
- ^ Skibitskiĭ, VV; Petrova; Kanorskiĭ (Jun 1992). "Comparative analysis of antiarrhythmic action and electrophysiological effects of a new benzodiazepine derivative gidazepam and ethacizin in arrhythmias of various genesis". Kardiologiia 32 (6): 35–7. ISSN 0022-9040. PMID 1405290.
- ^ Meerson, FZ; Skibitskiĭ (Apr 1992). "Comparative anti-arrhythmia effectiveness of activators of body stress-limiting systems in patients with arrhythmia". Kardiologiia 32 (4): 25–30. ISSN 0022-9040. PMID 1328745.
- ^ Andronati, SA; Zin'kovskiĭ; Totrova; Golovenko; Stankevich; Zhuk (Jan 1992). "Biokinetics of a new prodrug gidazepam and its metabolite". Biulleten' eksperimental'noi biologii i meditsiny 113 (1): 45–7. ISSN 0365-9615. PMID 1356504.
- ^ Kolyvanov, GB; Zherdev; Chirkov; Otabekova; Litvin (May 1993). "Gidazepam biotransformation and pharmacokinetics in different species of animals and man". Eksperimental'naia i klinicheskaia farmakologiia 56 (3): 48–50. ISSN 0869-2092. PMID 8106054.
- ^ Zherdev, VP; Neznamov; Kolyvanov; Litvin; Otabekova (May 1993). "The pharmacokinetic aspects of the clinical action of gidazepam". Eksperimental'naia i klinicheskaia farmakologiia 56 (3): 50–2. ISSN 0869-2092. PMID 8106055.
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
